--- title: "Aurora Cannabis (NASDAQ:ACB) Upgraded at Atb Cap Markets" description: "Atb Cap Markets upgraded Aurora Cannabis (NASDAQ: ACB) from a \"hold\" to a \"strong-buy\" rating in a recent report. Other brokerages, including TD Securities, have also issued positive ratings. Aurora C" type: "news" locale: "en" url: "https://longbridge.com/en/news/227518194.md" published_at: "2025-02-07T11:18:45.000Z" --- # Aurora Cannabis (NASDAQ:ACB) Upgraded at Atb Cap Markets > Atb Cap Markets upgraded Aurora Cannabis (NASDAQ: ACB) from a "hold" to a "strong-buy" rating in a recent report. Other brokerages, including TD Securities, have also issued positive ratings. Aurora Cannabis has a market cap of $342.86 million and reported earnings of $0.06 per share, exceeding estimates. Hedge funds have increased their stakes in the company, which operates in the cannabis sector, producing and selling cannabis products in Canada and internationally. Aurora Cannabis (NASDAQ:ACB - Get Free Report) was upgraded by equities research analysts at Atb Cap Markets from a "hold" rating to a "strong-buy" rating in a report issued on Wednesday,Zacks.com reports. Get **Aurora Cannabis** alerts: - Profit from the Green Wave: Top Cannabis Stocks to Watch Several other brokerages have also issued reports on ACB. TD Securities upgraded Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. TD Cowen began coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a "buy" rating for the company. **Read Our Latest Stock Report on ACB** ## Aurora Cannabis Stock Performance - The Cannabis Sector: Profitability Takes Center Stage NASDAQ ACB opened at $6.25 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. The company has a market capitalization of $342.86 million, a PE ratio of -8.22 and a beta of 1.84. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a 50-day simple moving average of $4.24 and a 200 day simple moving average of $5.16. Aurora Cannabis (NASDAQ:ACB - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%. On average, research analysts predict that Aurora Cannabis will post -0.1 EPS for the current year. ## Hedge Funds Weigh In On Aurora Cannabis - Aurora Cannabis Earnings Reveal a Turning Tide for the Stock Hedge funds have recently made changes to their positions in the stock. SBI Securities Co. Ltd. bought a new position in Aurora Cannabis in the 4th quarter valued at $31,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Aurora Cannabis in the second quarter worth $50,000. Wealthspire Advisors LLC bought a new stake in Aurora Cannabis during the fourth quarter valued at $149,000. Finally, Tidal Investments LLC boosted its stake in Aurora Cannabis by 2.7% during the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company's stock valued at $7,905,000 after buying an additional 34,988 shares during the period. 47.63% of the stock is currently owned by hedge funds and other institutional investors. ## Aurora Cannabis Company Profile (Get Free Report) Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. ## See Also - Five stocks we like better than Aurora Cannabis - Insider Trading - What You Need to Know - Price Plunge in Roblox Presents Opportunity for Robust Gains - EV Stocks and How to Profit from Them - Billions in Buybacks: 4 Stocks Rewarding Shareholders Now - Stock Splits, Do They Really Impact Investors? - 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list. They believe these five stocks are the five best companies for investors to buy now... See The Five Stocks Here ## Should You Invest $1,000 in Aurora Cannabis Right Now? Before you consider Aurora Cannabis, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list. While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [ACB.US - Aurora Cannabis](https://longbridge.com/en/quote/ACB.US.md) - [AUR.US - Aurora Innovation](https://longbridge.com/en/quote/AUR.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 极光大麻财报：第三季度概览 | Aurora Cannabis（纳斯达克代码：ACB）于 2026 年 2 月 4 日公布了第三季度财报，实际每股收益（EPS）为 0.021 美元，未能达到预期的 0.19 美元，差距达 89%。与去年同期相比，收入增加了 449 万美元 | [Link](https://longbridge.com/en/news/274813375.md) | | 极光大麻公司发布 2026 年第三季度管理层讨论与分析（MD&A）报告 | Aurora Cannabis Inc. 发布了其 2026 年第三季度管理层讨论与分析报告，强调其在加拿大的医疗和消费大麻产品的生产、分销和销售，以及在欧盟，特别是德国的批发医疗大麻。该公司还在将其医疗大麻分销扩展到国际市场，包括澳大利亚 | [Link](https://longbridge.com/en/news/274811263.md) | | Cannabix Technologies 宣布进行非经纪 LIFE 私募配售 | Cannabix Technologies Inc. 宣布进行一项非承销的私人配售，计划通过发行 1,000,000 到 2,000,000 个单位，每个单位价格为 0.50 加元，筹集 500,000 加元至 1,000,000 加元。每 | [Link](https://longbridge.com/en/news/275184611.md) | | 极光大麻公司将抗白粉病大麻推进至生产试验阶段 | 极光大麻已在其 Aurora Ridge 设施推进了对白粉病抗性研究，宣布进行生产试验。该公司旨在通过遗传抗性源 PM2 增强疾病抗性，同时保持质量特性。这项工作已在多个会议上展示，目前在主要市场申请专利。尽管分析师对其给予持有评级，目标价 | [Link](https://longbridge.com/en/news/272555187.md) | | 极光大麻宣布了一项新的市价增发股票计划，金额高达 1 亿美元 | Aurora Cannabis Inc. 宣布了一项新的市场发行计划，允许发行和销售最多 1 亿美元的普通股。所得款项将用于战略和增值目的，包括增加生产能力和潜在收购。这些股票将在与 TD Securities (USA) LLC 的分销协 | [Link](https://longbridge.com/en/news/274809352.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.